We’ve long known that the way couples divide housework can have a serious impact on a woman’s career. For example, in her 2013 book Lean In, Facebook COO Sheryl Sandberg advises women that unless their partners pitch in with at least 50 percent of the housework and childcare, they may not advance as much as they would like to in their workplace.
Research backs this up: One reason there are so few women in leadership positions could be because women continue to do the majority of housework and childcare even in households in which both partners work full-time, according to a McKinsey study.
Now, a new study finds that women who work more than 60 hours a week are at a higher risk of several chronic diseases. And the researcher who found this connection suspects that an unequal division of domestic labor may be to blame, because the same risk increases aren’t seen in men.
In a study of a national survey data, it was discovered that women who worked 60-plus hours every week over three decades have triple the risk of early-onset diabetes, heart disease, arthritis, and certain kinds of cancer compared to women who work the more standard 30- to 40-hour week. They also had about double the risk of chronic lung disease and asthma.
These results are alarming enough, but are even more so when you consider that these are just the women who were diagnosed early, between the ages of 40 and 50. The study doesn’t reveal lifetime risk for these chronic …
The objective of this attempt at clarification is to discuss the contributions of this discipline to everyday surgical activity, to provide surgeons with some tools facilitating initial evaluation of their patients, and to remind the reader of situations in which oncological assistance is of paramount importance.
Algorithm may help better predict how likely it is a woman will have cancer in her future.
Conclusion: MRI-linac based single dose APBI to the intact tumor is a promising and a dosimetrically feasible strategy in patients with low-risk breast cancer. Preliminary OAR dosimetry favored the prone radiotherapy position.
PMID: 30406210 [PubMed]
One of the biotech industry’s largest unicorns, Cambridge-based Moderna Therapeutics, is planning to go public with an IPO of as much as $500 million, according to documents filed Friday.
Moderna is developing messenger RNA molecules, including cancer vaccines, that executives estimates could impact dozens of diseases. The company currently has 10 drug products in clinical trials and another 11 drugs in preclinical development.
The company filed documents with the SEC on Friday t o seek up to…
NIH Director’s Wednesday Afternoon Lecture Series – Special Tuesday Lecture
The major interest of Dr. Hotamisligil’s laboratory is to study the regulatory pathways, which control glucose and lipid metabolism. His lab’s biochemical and genetic studies focus on signal transduction using cultured mammalian cells as well as transgenic animals to identify specific abnormalities in these pathways, which are involved in human metabolic and inflammatory diseases including obesity, diabetes, fatty liver disease, atherosclerosis, and asthma.For more information go tohttps://oir.nih.gov/walsAir date: 11/13/2018 3:00:00 PM
Curriculum transformation, An expanded role, Gaining recognition, Graduate match rate; School of Pharmacy scientists receive UCSF Medal: Founding fathers of drug discovery honored; Beyond drugs, Two artificial pancreas projects, Bringing prosthetics to patients; Beyond drugs, Two artificial pancreas projects, Bringing prosthetics to patients; Advancing the fight against cancer, Combining drug therapies, Mapping cells; In memoriam: Robert D. Gibson
A lifetime of pharmacy and advocacy
ConclusionThe level of CRF, MF has association with MS in men. This study suggests that we need to manage our fitness to prevent MS.